Analgesia Nociceptive Index for in Cirrhotic Patients Undergoing Hepatic Resection

Analgesia Nociceptive Index for Nociception Monitoring in Cirrhotic Patients Undergoing Hepatic Resection: Randomized Control Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202401852393337

Enrollment

Registered

2024-01-09

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

control group

ANI group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.cirrhotic patients candidate for hepatic resection 2. Child classification (A)

Exclusion criteria

Exclusion criteria: 1.patients suffered from Major intraoperative events (e.g. severe hemodynamic instability, massive blood loss, . 2. Allergic patients to any of the study drugs, Opioid addiction, 3. Body-mass index higher than 40 kg/m²and 4. when ANI measurement cannot be interpreted arrhythmia, pace maker (certain types) heart transplant drugs affecting the sinus node (atropine and other anticholinergic drugs,

Design outcomes

Primary

Measure	Time frame
investigate the ability of analgesia nociceptive index (ANI) compared to traditional method(elevated heart rate and mean blood pressure) to decrease opioid consumption during hepatic focal lesion resection	—

Secondary

Measure	Time frame
haemodynamic changes . postoperative complication	—

Countries

Egypt

Contacts

Public Contacthanaa rashed

anasthesia lecturer

hanaarashed2020@yahoo.com01001378542

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026